T-Cell Prolymphocytic Leukemia: An Experience from a Tertiary Cancer Centre in South India

Background: T-cell prolymphocytic leukemia (T-PLL) is a rare lymphoid malignancy with dismal prognosis. Most patients have increased lymphocyte count (>1,00,000/dL) and widespread disease at presentation. Despite high response rate seen with alemtuzumab, the disease relapse is inevitable. Materia...

Descripción completa

Detalles Bibliográficos
Autores principales: Babu MC, Suresh, Anand, Abhishek, Lakshmaiah, Kuntegowdanahalli C., Babu K, Govind, Lokanatha, Dasappa, Jacob, Linu Abraham, Madhumathi, DS, Lokesh, Kadabur N, Rudresha, AH, Rajeev, LK, Patidar, Rajesh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Tehran University of Medical Sciences, Hematology-Oncology and Stem Cell Transplantation Research Center 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6141430/
https://www.ncbi.nlm.nih.gov/pubmed/30233775

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6141430/
https://www.ncbi.nlm.nih.gov/pubmed/30233775

Ejemplares similares